• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Trupanion Appoints Aflac Incorporated CFO Max Brodén to Board of Directors

    7/5/23 9:00:00 AM ET
    $TRUP
    Medical Specialities
    Health Care
    Get the next $TRUP alert in real time by email

    SEATTLE, July 05, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) announced that Max Brodén, Chief Financial Officer of Aflac Incorporated, has been appointed to serve as an independent director effective July 4, 2023. This appointment expands the Board to nine directors, eight of whom are independent.

    "We're excited to welcome Max as the newest independent member of our Board," said Darryl Rawlings, Founder, CEO and Chair of the Board. "Max's global financial knowledge and expertise in both the insurance and investment industries, including as CFO for the largest publicly traded supplemental health insurance company, will be extremely valuable to Trupanion."

    "Max is a natural leader with proven results as a public insurance company executive," said Murray Low, PhD, Lead Independent Director. "We remain focused on ensuring our board has the right mix of skills and experience and we are thrilled to have Max join given his record of value creation and how complementary his qualifications are to the rest of our directors."  

    With over 17 years of experience and leadership managing global financial and insurance portfolios, Mr. Brodén is currently the Executive Vice President and Chief Financial Officer of Aflac Incorporated where he has served in various leadership roles of ascending responsibility since April 2017. Before joining Aflac Incorporated, Mr. Brodén served as senior portfolio manager at Norges Bank from 2007 to 2017, managing an equity portfolio of global financial and insurance stocks. Mr. Brodén holds a Master of Science in both accounting and finance from Stockholm School of Economics.

    As part of the ongoing refreshment of Trupanion's Board of Directors, six directors have now been appointed in the past six years.

    About Trupanion

    Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, Europe, Puerto Rico and Australia with over 900,000 pets enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance with unlimited payouts for the life of their pets. With its patented process, Trupanion is the only North American provider with the technology to pay veterinarians directly in seconds at the time of checkout. Trupanion is listed on NASDAQ under the symbol "TRUP". The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. Trupanion Australia is a partnership between Trupanion and Hollard Insurance Company. For more information, please visit trupanion.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to, among other things, expectations, plans, prospects and financial results for Trupanion, including, but not limited to, its expectations regarding its ability to continue to grow its enrollments and revenue, and otherwise execute its business plan. These forward-looking statements are based upon the current expectations and beliefs of Trupanion's management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements made in this press release are based on information available to Trupanion as of the date hereof, and Trupanion has no obligation to update these forward-looking statements.

    In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the ability to achieve or maintain profitability and/or appropriate levels of cash flow in future periods; the ability to keep growing our membership base and revenue; the accuracy of assumptions used in determining appropriate member acquisition expenditures; the severity and frequency of claims; the ability to maintain high retention rates; the accuracy of assumptions used in pricing medical plan subscriptions and the ability to accurately estimate the impact of new products or offerings on claims frequency; actual claims expense exceeding estimates; regulatory and other constraints on the ability to institute, or the decision to otherwise delay, pricing modifications in response to changes in actual or estimated claims expense; the effectiveness and statutory or regulatory compliance of our Territory Partner model and of our Territory Partners, veterinarians and other third parties in recommending medical plan subscriptions to potential members; the ability to retain existing Territory Partners and increase the number of Territory Partners and active hospitals; compliance by us and those referring us members with laws and regulations that apply to our business, including the sale of a pet medical plan; the ability to maintain the security of our data; fluctuations in the Canadian currency exchange rate; the ability to protect our proprietary and member information; the ability to maintain our culture and team; the ability to maintain the requisite amount of risk-based capital; our ability to implement and maintain effective controls, including over financial reporting; the ability to protect and enforce Trupanion's intellectual property rights; the ability to successfully implement our alliance with Aflac; the ability to continue key contractual relationships with third parties; third-party claims including litigation and regulatory actions; the ability to recognize benefits from investments in new solutions and enhancements to Trupanion's technology platform and website; and our ability to retain key personnel.

    For a detailed discussion of these and other cautionary statements, please refer to the risk factors discussed in filings with the Securities and Exchange Commission (SEC), including but not limited to, Trupanion's Annual Report on Form 10-K for the year ended December 31, 2022 and any subsequently filed reports on Forms 10-Q, 10-K and 8-K. All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval system at https://www.sec.gov/or the Investor Relations section of Trupanion's website at https://investors.trupanion.com/.

    Contacts:

    Laura Bainbridge, Vice President, Corporate Communications

    [email protected]



    Primary Logo

    Get the next $TRUP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TRUP

    DatePrice TargetRatingAnalyst
    1/23/2025$57.00Neutral → Overweight
    Piper Sandler
    7/19/2024Outperform
    William Blair
    5/16/2024$35.00 → $49.00Neutral → Buy
    BofA Securities
    5/8/2023$72.00 → $32.00Buy → Neutral
    BofA Securities
    9/21/2022$77.00Buy
    Jefferies
    8/4/2022$80.00 → $69.00Overweight → Neutral
    Piper Sandler
    2/24/2022$129.00 → $118.00Neutral → Buy
    B of A Securities
    12/8/2021$126.00 → $183.00Overweight
    Piper Sandler
    More analyst ratings

    $TRUP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Trupanion upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00

      1/23/25 7:55:01 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • William Blair initiated coverage on Trupanion

      William Blair initiated coverage of Trupanion with a rating of Outperform

      7/19/24 7:44:19 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion upgraded by BofA Securities with a new price target

      BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously

      5/16/24 7:37:42 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Trupanion Announces Winners of the Veterinary Appreciation Day™ Awards

      SEATTLE, June 18, 2025 (GLOBE NEWSWIRE) -- In honor of Veterinary Appreciation Day on June 18, Trupanion, the leading provider of medical insurance for cats and dogs in North America, held its annual awards event to celebrate and recognize the veterinary community for their profound impact on the lives of pets and their families. This year, the awards program saw an incredible outpouring of gratitude across North America, receiving more than 47,000 public votes. From the thousands of nominees, just 12 winners were chosen based on their significant influence on their veterinary teams, pet parents, and the communities they serve. "This year's record-breaking voter turnout shows how

      6/18/25 4:05:40 PM ET
      $TRUP
      Medical Specialities
      Health Care
    • Grindr Appoints Veteran Public Company CFO and Audit Committee Chair Chad Cohen to Board of Directors

      Cohen to serve as Chair of the Audit Committee Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced the appointment of Chad Cohen, former Chief Financial Officer of Zillow Group Inc. (NASDAQ:Z) and Adaptive Biotechnologies Corp. (NASDAQ:ADPT) and Founding Partner of Scala Advisors, LLC, to Grindr's Board of Directors as of June 3, 2025. Cohen was also appointed to serve as the Chair of Grindr's Audit Committee. A seasoned public company finance executive and board member, Cohen has helped grow several multi-billion dollar technology companies, including multiple leading consumer Internet brands. Prior to his current role, Cohen served as the Chief Financial Of

      6/3/25 4:05:00 PM ET
      $ADPT
      $GRND
      $TRUP
      $VCSA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Computer Software: Programming Data Processing
      Technology
    • Trupanion to Present at the William Blair 45th Annual Growth Stock Conference

      SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today that Margi Tooth, Chief Executive Officer and President, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, at 3:20 p.m. CT and will participate in meetings with investors throughout the day. The presentation will be webcast live and can be accessed on Trupanion's Investor Relations website at http://investors.trupanion.com. About Trupanion: Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, and certain countries in Continental Europe with over 1,000,000 pets

      5/28/25 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care

    $TRUP
    Leadership Updates

    Live Leadership Updates

    See more
    • Grindr Appoints Veteran Public Company CFO and Audit Committee Chair Chad Cohen to Board of Directors

      Cohen to serve as Chair of the Audit Committee Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced the appointment of Chad Cohen, former Chief Financial Officer of Zillow Group Inc. (NASDAQ:Z) and Adaptive Biotechnologies Corp. (NASDAQ:ADPT) and Founding Partner of Scala Advisors, LLC, to Grindr's Board of Directors as of June 3, 2025. Cohen was also appointed to serve as the Chair of Grindr's Audit Committee. A seasoned public company finance executive and board member, Cohen has helped grow several multi-billion dollar technology companies, including multiple leading consumer Internet brands. Prior to his current role, Cohen served as the Chief Financial Of

      6/3/25 4:05:00 PM ET
      $ADPT
      $GRND
      $TRUP
      $VCSA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Computer Software: Programming Data Processing
      Technology
    • Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System

      Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits  SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B

      8/14/24 9:00:00 AM ET
      $TRUP
      Medical Specialities
      Health Care
    • Trupanion's Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024

      SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he

      5/2/24 4:04:29 PM ET
      $TRUP
      Medical Specialities
      Health Care